Breast cancer (BC) is a serious worldwide disease that threatens women's health.
Particularly, the morbidity of triple-negative breast cancer (TNBC) is higher than that of other …

The crucial role of the immune system in the progression/regression of breast cancer (BC)
should always be taken into account. Various immunotherapy approaches have been …

The immune system is critical in modulating cancer progression, but knowledge of immune
composition, phenotype, and interactions with tumor is limited. We used multiplexed ion …

Current studies have shown that long non‐coding RNAs (lncRNAs) may serve as prognostic
biomarkers in multiple cancers. Therefore, we postulated that expression patterns of multiple …

Breast cancer can be classified based on the expression or lack of expression of protein
receptors including estrogen receptor (ER), progesterone receptor (PR) and human …

Breast cancer is a severe problem worldwide due to an increase in mortality and prevalence
among women. Despite early diagnostic procedures as well as advanced therapies, more …

Invasive lobular carcinoma (ILC) is the second most common histological subtype of breast
cancer following invasive ductal carcinoma (IDC). ILC differs from IDC in a number of …

Breast cancer is the leading cause of death in women from 20 to 59 years old. The
conventional treatment includes surgery, chemotherapy, hormonal therapy, and …

Breast cancer is the leading cause of cancer death in female. Until now, advanced breast
cancer is still lack effective treatment strategies and reliable prognostic markers. In the …

Background Triple negative breast cancer (TNBC) is an aggressive disease, but recent
studies have identified heterogeneity in patient outcomes. However, the utility of histologic …